CorreGene
Beijing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Gene therapy biotech focused on developing one-time curative treatments for rare genetic diseases.
Rare DiseaseGene TherapyGenetics & Genomics
Technology Platform
Platform for designing and manufacturing novel viral vectors and gene editing constructs aimed at precise genetic correction.
Opportunities
The high unmet need and often favorable regulatory incentives for rare disease therapies offer a clear path for valuable, targeted treatments.
Risk Factors
Faces substantial scientific risks related to long-term safety and efficacy of gene therapies, alongside complex manufacturing and high cost challenges.
Competitive Landscape
Operates in the highly competitive and technically challenging global gene therapy arena, requiring significant R&D investment to differentiate.